Not Just Another Index.
It’s The New Generation.®
We offer specialized solutions for investors seeking exposure to New Listings - a proxy for economic growth and innovation.
Upcoming Global IPOs
Accelevation (Ticker: ACCV US) is a U.S.-registered infrastructure company that designs, manufactures and installs power distribution and white-space infrastructure products for mission-critical environments, serving hyperscale, colocation, AI, cloud and other large-scale data center customers.
Accelevation is expected to list on Nasdaq on September 30, 2026, following pricing after market close on September 29. The company plans to offer 30 million shares at $20.00-$24.00 per share, implying an IPO size of approximately $660 million at the midpoint and a range of $600 million-$720 million. According to the published terms, the offering consists of approximately 29% primary shares and 71% synthetic secondary shares. J.P. Morgan and Morgan Stanley are serving as bookrunners, with Morgan Stanley acting as stabilization agent and bill-and-deliver bank.
Duksan Navcours Co., Ltd. (Ticker: 266690 KS) is a South Korean aerospace and defense technology company specializing in positioning, navigation and timing (PNT) systems, including precision satellite navigation, GNSS/INS navigation and anti-jamming solutions for military, aerospace and civilian applications.
Duksan Navcours plans to list on KOSDAQ on September 30, 2026. The company priced its IPO at KRW 14,600 per share, at the top of the indicated KRW 12,400-14,600 range, offering 3 million shares and raising approximately KRW 44 billion (approximately $30 million). The offering consists entirely of primary shares. At the IPO price, Duksan Navcours has an estimated market capitalization of approximately $189 million. Daishin Securities is acting as manager of the offering. The company was founded in 2012, is headquartered in Daejeon, South Korea, and has been part of the Duksan Group since 2021.
Shenzhen Camsense Technologies Co., Ltd. (Ticker: 6802 HK) is a Chinese spatial sensing technology company that develops sensors, algorithms and hardware, with a focus on LiDAR and line laser products used in robotic vacuums and other robotics applications. Camsense plans to list in Hong Kong on September 30, 2026, offering approximately 11.59 million primary shares at HKD 58.85 per share.
The IPO is expected to raise approximately HKD 682 million (approximately $87 million), with a 15% greenshoe facility covering approximately 1.74 million additional shares. At the offer price, the company is valued at approximately $725 million. Camsense is offering H shares, with primary shares representing 100% of the base offering. Its products serve robotics, industrial and medical applications, and the company has also been expanding its spatial sensing technology into areas including yard robots, pool-cleaning robots and humanoid robots.
Beijing ESWIN Computing Technology Co., Ltd. (Ticker: 1256 HK) is a Chinese semiconductor company focused on RISC-V-based chips, chipsets, circuit boards and related software for smart devices, automotive, robotics and industrial applications. The company also provides semiconductor packaging, testing and wafer-related services.
Eswin Computing plans to list on the Hong Kong Stock Exchange on October 9, 2026, offering approximately 1.57 billion primary shares at an expected price range of HKD 1.48 to HKD 1.59 per share. At the top of the range, the IPO is expected to raise approximately HKD 2.50 billion (approximately $318 million). The supplied calendar data indicates an estimated valuation of around $4.3 billion. The offering also includes a 15% greenshoe facility covering approximately 236 million shares. CLSA, CMB International Capital, China Securities International, GF Securities Hong Kong, Huatai Financial Holdings Hong Kong and other firms are among the offering managers.
The IPOX® Newsletters
IPOX® in the News
Reuters reports that Accelevation is targeting a valuation of up to $5.37 billion in its U.S. IPO, seeking to raise up to $720 million. IPOX® Vice President Kat Liu said investors are becoming more selective as AI infrastructure offerings expand, focusing on companies’ value-chain positioning, backlog quality, and ability to convert demand into revenue, margins, and cash flow. Accelevation provides power distribution, cooling, and modular infrastructure for data centers supporting growing AI computing demand.
IPOX® CEO Josef Schuster commented in Barron's on how growing retail access to IPO allocations through platforms such as Robinhood, SoFi and Coinbase could influence short-term trading in newly listed companies. Discussing Oura’s upcoming IPO, Schuster noted that restrictions on future IPO access may discourage investors from quickly selling allocated shares, potentially affecting early trading dynamics. The article also highlighted IPOX®’s broader role in IPO market research and its index tracked by the First Trust US Equity Opportunities ETF.
IPOX® Associate Lukas Muehlbauer was interviewed by Kauppalehti, Finland’s leading business and financial newspaper, about Oura’s planned U.S. IPO and growth outlook. The article examines Oura’s strong revenue momentum, targeted $12.8–14.1 billion valuation and offering structure. Muehlbauer discussed how the valuation reflects significant future growth expectations and noted that much of the stock being offered comes from existing shareholders, meaning Oura itself is expected to receive only a portion of the proceeds raised through the transaction as part of the IPO.
Reuters reports that ADARx Pharmaceuticals raised $446.3 million in an upsized U.S. IPO, with shares opening 30% above the $17 offer price. IPOX® Associate Lukas Muehlbauer, who commented ahead of the offering on AbbVie’s backing and biotech investor selectivity, spoke with Reuters again after the company began trading. He highlighted AbbVie’s validation, ADARx’s Phase 3 lead drug and broader development platform, while noting that investors remain focused on mature clinical assets and key catalyst milestones across the biotech IPO market.
IPOX® VP Kat Liu comments on Oura’s planned U.S. IPO, which targets a fully diluted valuation of about $15.6 billion and could raise up to $2.2 billion. Liu highlighted Oura’s beginner-friendly, fashionable positioning in wearables, while noting that the valuation reflects expectations for continued strong growth and a greater shift toward higher-margin recurring revenue. Oura is expected to price next week and trade on Nasdaq under the ticker OURA, following its fall roadshow launch.
The IPOX® Update
Global IPO activity accelerated across major markets, led by large technology, infrastructure, fintech and healthcare offerings. Nscale, Oura, Accelevation, ADARx and Bamboo Insurance drove U.S. activity, while Anthropic continued IPO preparations. In Europe, Airtel Money advanced its London listing and Trafigura prepared Volare Shipping for Oslo. Asia-Pacific remained especially active, with Firmus, Mynt, EcoCeres, Kinwong Electronic, Direct Drive Tech and Camsense pursuing sizable listings across Australia, the Philippines and Hong Kong. Investor demand remains focused on AI-linked and growth companies.
Global IPO activity this week featured several large planned offerings alongside notable delays. Firmus Technologies is seeking up to $5 billion in Australia, while Bamboo Insurance targets up to $700 million in New York. BASF advanced plans for a major Frankfurt listing, and Revolut and Vue explored future London-linked IPOs. Holtec, Dusk and Forms Syntron postponed or shelved offerings. Other deals included Linjemontage in Stockholm, Wiluna Mining in Australia and RoboTechnik’s $800 million Hong Kong secondary listing during the period.
Global IPO activity is accelerating into the fall, with major prospective listings spanning the U.S., Europe, Asia-Pacific and MENA. Altera leads the pipeline with a potential $2 billion-plus U.S. IPO, while Holtec Nuclear, Stratolaunch and Orion180 advance offerings. Europe features Belron and Ignis, while Asia-Pacific activity includes AirTrunk, Mynt, Musinsa and Transwarp Technology. In MENA, MNT-Halan has begun the Cairo listing process, highlighting broad investor appetite across technology, infrastructure, defense, insurance and fintech as issuance momentum builds toward year-end globally.